As healthcare professionals, it's paramount to comprehend the complexities of neurodegenerative disorders, such as Parkinson's disease (PD). PD, a chronic and progressive movement disorder, affects millions worldwide, with the prevalence increasing with age.
The exact cause of PD remains unknown. However, it's generally accepted that a combination of genetic and environmental factors contribute to the development of the disease. Pathologically, PD is characterized by the loss of dopamine-producing cells in the substantia nigra, leading to motor and non-motor symptoms.
PD typically presents with motor symptoms including bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms such as cognitive impairment, mood disorders, autonomic dysfunction, and sleep disturbances are also common and can significantly impact the quality of life.
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy. Neuroimaging, although not routinely used, can aid in uncertain cases or to differentiate PD from other parkinsonian syndromes.
Management of PD is symptomatic and individualized, involving pharmacological interventions, physical therapy, and surgical options for refractory cases. The mainstay of treatment is dopaminergic therapy, which can significantly improve motor symptoms. However, addressing non-motor symptoms and improving overall quality of life is equally important.
Understanding PD is crucial for healthcare professionals to provide optimal care. While our knowledge of PD has greatly expanded, many aspects remain elusive. Continuous research is required to further unravel the pathophysiological mechanisms, improve diagnostic accuracy, and develop more effective treatment strategies.
1.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
2.
Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection
3.
Implant-based reconstruction linked to increased risk of breast lymphomas
4.
Adult overdose deaths on the rise
5.
Simpler Screening Criteria Could Catch More Lung Cancers
1.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
2.
Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options
3.
Patient Management for Bone Marrow Functional Recovery Pathways
4.
Engineered Red Blood Cell Therapeutics: Emerging Applications
5.
The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation